Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR3C1 | P04150 | 4/20 | 0.38 |
| ▸ | PGR | P06401 | 3/20 | 0.38 |
| ▸ | BRD4 | O60885 | 14/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | BRD2 | P25440 | 2/20 | 0.33 |
| ▸ | BRD3 | Q15059 | 2/20 | 0.33 |
| ▸ | CREBBP | Q92793 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27704549 | 0.83 | NR3C1 (0.39) | NR3C1PGRBRD4 | |
| SCHEMBL27685670 | 0.79 | NR3C1 (0.37) | NR3C1PGR | |
| SCHEMBL5505662 | 0.78 | NR3C1 (0.61) | NR3C1PGRBRD4TSHRBRD2 | |
| SCHEMBL27704553 | 0.77 | NR3C1 (0.64) | NR3C1PGR | |
| SCHEMBL5508573 | 0.72 | NR3C1 (0.53) | NR3C1PGRBRD4BRD2CREBBP | |
| SCHEMBL27704554 | 0.71 | NR3C1 (0.39) | NR3C1PGRBRD4 | |
| SCHEMBL5501180 | 0.69 | NR3C1 (0.57) | NR3C1PGRBRD4 | |
| SCHEMBL5503098 | 0.67 | NR3C1 (0.53) | NR3C1PGR | |
| SCHEMBL5504585 | 0.67 | NR3C1 (0.53) | NR3C1PGR | |
| SCHEMBL5504581 | 0.67 | NR3C1 (0.53) | NR3C1PGR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101018552-A | Intracellular receptor modulator compounds and methods | LIGAND PHARM INC (US) | 2007-08-15 | — | — | CN | claimed |
| CN-101018552-A | Intracellular receptor modulator compounds and methods | LIGAND PHARM INC (US) | 2007-08-15 | — | — | CN | disclosed |